Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QR4M | ISIN: FI4000490875 | Ticker-Symbol: 7XE
Frankfurt
27.06.25 | 08:02
2,585 Euro
+1,37 % +0,035
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NIGHTINGALE HEALTH OYJ Chart 1 Jahr
5-Tage-Chart
NIGHTINGALE HEALTH OYJ 5-Tage-Chart
RealtimeGeldBriefZeit
2,5602,72013:03

Aktuelle News zur NIGHTINGALE HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
NIGHTINGALE HEALTH Aktie jetzt für 0€ handeln
10.04.Nightingale Health Oyj: Nightingale Health's laboratory implementation in the United States progresses as planned - opens first to medical research customers in Summer 2025116Nightingale Health Plc | Press Release | April 10, 2025 at 09:30:00 EEST Nightingale Health Plc Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF) a pioneer in disease risk detection...
► Artikel lesen
25.03.Citi Appointed as Depositary Bank for Nightingale Health OYJ's ADR Program314Citi Issuer Services, acting through Citibank N.A., has been appointed by Nightingale Health OYJ ("Nightingale Health") to act as depositary bank for its sponsored Level 1 American Depositary Receipt...
► Artikel lesen
21.03.Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US1
21.03.OTC Markets Group Welcomes NIGHTINGALE HEALTH OYJ to OTCQX1
19.03.Nasdaq Helsinki welcomes Nightingale Health to Main Market16119 March 2025, Helsinki - Nasdaq (Nasdaq: NDAQ) announces that trading in Nightingale Health Plc shares (ticker: HEALTH) will commence today on the Main Market of Nasdaq Helsinki. Nightingale Health...
► Artikel lesen
18.03.Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 20251
18.03.Nightingale Health Plc: Move From Nasdaq First North Growth Market Finland To The Official List163EXCHANGE NOTICE, 18 MARCH 2025 SHARES NIGHTINGALE HEALTH PLC: MOVE FROM NASDAQ FIRST NORTH GROWTH MARKET FINLAND TO THE OFFICIAL LIST At the request of Nightingale Health Plc, the...
► Artikel lesen
17.03.The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus1
17.03.Nightingale Health Oyj: Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the ...144Nightingale Health Plc Stock exchange release 17 March 2025 at 1:55 p.m. (EET)Nightingale Health Plc ("Nightingale Health" or the "Company") announced on 27 November 2024 that it was investigating...
► Artikel lesen
12.03.Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki3
06.03.Nightingale Health Oyj: Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States342Nightingale Health Group's Half-year report 1 July 2024 - 31 December 2024 (unaudited) Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States Company...
► Artikel lesen
28.02.Nightingale Health to publish half-year report for July - December 2024 on 6 March 20251
27.02.Nightingale Health announces the development of innovative LLM based tool to empower anyone to take informed decisions to lower disease risks2
07.02.Nightingale Health Oyj: Nightingale Health announces its updated regulatory plan in the United States178Nightingale Health Plc Press release 7 February 2025 at 2:15 p.m. (EET)Nightingale Health Plc ("Nightingale Health"), a pioneer in disease risk detection and preventative health announces its regulatory...
► Artikel lesen
27.01.Nightingale Health and Enigma Genomics enter into collaboration to sell the Nightingale Remote Health Check in the MENA region1
23.01.Nightingale Health announces the performance metrics of its latest generation disease risk assessments to be rolled out in Singapore and the United States1
20.09.24Nightingale Health Oyj: Nightingale Health Plc Financial Statements Release 1 July 2023 - 30 June 2024131Nightingale Health Plc Company release 20 September 2024 at 9:00 a.m. (EEST)Nightingale Health Group's Financial Statements Release 1 July 2023 - 30 June 2024 (unaudited) Nightingale's Financial Statements...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1